Literature DB >> 25523388

Convexity Subarachnoid Hemorrhage with PiB Positive Pet Scans: Clinical Features and Prognosis.

John V Ly1, Shaloo Singhal, Christopher C Rowe, Peter Kempster, Simon Bower, Thanh G Phan.   

Abstract

BACKGROUND: Cerebral amyloid angiopathy (CAA) has been reported to present as convexity subarachnoid hemorrhage (cSAH). Lesser known is that cSAH can herald intracerebral hemorrhage (ICH) and ischemic lesions. We present seven new cases with (11) C-Pittsburgh compound B (PiB) positive positron emission tomography (PET) scans including two with biopsy, review the literature and comment on clinical and radiological findings.
METHODS: Patients with cSAH identified on CT, underwent MR imaging and MR angiography to exclude intracranial aneurysm. Nonaneurysmal cSAH were further prospectively evaluated for amyloid angiopathy using PiB. Clinical and radiological features of cSAH, subsequent ICH and ischemic lesions were characterized.
RESULTS: Seven patients with nonaneurysmal cSAH fulfilled the Boston criteria for probable CAA. All had PiB PET scans consistent with CAA. Of the 4 patients who had contrast MR Imaging all had enhancement overlying the cSAH, followed by ICH in three cases. All patients presented with transient sensory symptoms. All patients had small punctate subcortical and cortical infarcts on diffusion-weighted MR imaging. Literature review revealed subsequent ICH in approximately 11/79 patients.
CONCLUSION: The finding of cSAH and PiB binding in our patients suggest underlying CAA. cSAH may be associated with ischemic lesion as well as future ICH occurrence.
Copyright © 2014 by the American Society of Neuroimaging.

Entities:  

Keywords:  ICH; PiB PET; beta amyloid; cerebral amyloid; cerebral amyloid angiopathy; convexity subarachnoid hemorrhage; diffusion-weighted imaging; positron emission topography

Mesh:

Substances:

Year:  2014        PMID: 25523388     DOI: 10.1111/jon.12188

Source DB:  PubMed          Journal:  J Neuroimaging        ISSN: 1051-2284            Impact factor:   2.486


  7 in total

1.  Convexity subarachnoid hemorrhage in cerebral amyloid angiopathy: the saga continues.

Authors:  Andreas Charidimou
Journal:  J Cereb Blood Flow Metab       Date:  2015-02-18       Impact factor: 6.200

2.  Incidence of Convexal Subarachnoid Hemorrhage in the Elderly: The Mayo Clinic Study of Aging.

Authors:  Micah Yost; Catherine Arnold Fiebelkorn; Alejandro A Rabinstein; James Klaas; Jeremiah A Aakre; Robert D Brown; Michelle M Mielke; David S Knopman; Val Lowe; Ronald C Petersen; Clifford R Jack; Prashanthi Vemuri; Jonathan Graff-Radford
Journal:  J Stroke Cerebrovasc Dis       Date:  2019-10-24       Impact factor: 2.136

3.  Prevalence of Brain MRI Markers of Hemorrhagic Risk in Patients with Stroke and Atrial Fibrillation.

Authors:  Christopher Karayiannis; Cathy Soufan; Ronil V Chandra; Thanh G Phan; Kitty Wong; Shaloo Singhal; Lee-Anne Slater; John Ly; Chris Moran; Velandai Srikanth
Journal:  Front Neurol       Date:  2016-09-20       Impact factor: 4.003

Review 4.  Amyloid positron emission tomography in sporadic cerebral amyloid angiopathy: A systematic critical update.

Authors:  Karim Farid; Andreas Charidimou; Jean-Claude Baron
Journal:  Neuroimage Clin       Date:  2017-05-05       Impact factor: 4.881

5.  Convexity subarachnoid haemorrhage has a high risk of intracerebral haemorrhage in suspected cerebral amyloid angiopathy.

Authors:  D Wilson; I C Hostettler; G Ambler; G Banerjee; H R Jäger; D J Werring
Journal:  J Neurol       Date:  2017-02-02       Impact factor: 4.849

6.  Incidence and possible causes of nontraumatic convexal subarachnoid haemorrhage in Chinese patients: A retrospective review.

Authors:  Haiyan Zhao; Jintao Han; Ming Lu; Yingshuang Zhang; Dongsheng Fan
Journal:  J Int Med Res       Date:  2016-07-07       Impact factor: 1.671

7.  Application Value of CTA in the Computer-Aided Diagnosis of Subarachnoid Hemorrhage of Different Origins.

Authors:  Wei Li; Lin Qi; Yulong Guo; Zhen Zhang; Guanglong He; Yang Li; Zhenyuan Wang
Journal:  J Healthc Eng       Date:  2021-01-15       Impact factor: 2.682

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.